Successful Extraction of Actinium-225 with Radionuclidic Purity Exceeding 99.99%
NovAccel has successfully achieved the extraction of Actinium-225 with over 99.99% purity using their proprietary compact accelerator.
📋 Article Processing Timeline
- 📰 Published: April 20, 2026 at 09:30
- 🔍 Collected: April 20, 2026 at 10:01 (31 min after Published)
- 🤖 AI Analyzed: April 20, 2026 at 10:56 (55 min after Collected)
NovAccel aims to provide new therapeutic hope to cancer patients worldwide by researching and developing technology to produce Ac-225 using a proprietary compact accelerator, through the collaboration of medical and accelerator experts.